Cite

HARVARD Citation

    Tini, P. et al. (2016). Combining Ipilimumab and Bevacizumab in Glioblastoma is Really Safe and Effective?. Clinical oncology. 28 (10), pp. 663-. [Online]. 
  
Back to record